<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26834728</article-id><article-id pub-id-type="pmc">4724717</article-id><article-id pub-id-type="doi">10.3389/fmicb.2016.00010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Therapeutic Application of Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral <italic>Candida</italic> Infections: A Mini Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ohshima</surname><given-names>Tomoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/218723/overview"/></contrib><contrib contrib-type="author"><name><surname>Kojima</surname><given-names>Yukako</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seneviratne</surname><given-names>Chaminda J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/185643/overview"/></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Nobuko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Oral Microbiology, School of Dental Medicine, Tsurumi University</institution><country>Kanagawa, Japan</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Oral Sciences, Faculty of Dentistry, National University of Singapore</institution><country>Singapore, Singapore</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: <italic>Tzi Bun Ng, The Chinese University of Hong Kong, China</italic></p></fn><fn fn-type="edited-by"><p>Reviewed by: <italic>Atte Von Wright, University of Eastern Finland, Finland; Abhishek Saxena, TERI University, India</italic></p></fn><corresp id="fn001">*Correspondence: <italic>Tomoko Ohshima, <email xlink:type="simple">ohshima-t@fs.tsurumi-u.ac.jp</email></italic></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>7</volume><elocation-id>10</elocation-id><history><date date-type="received"><day>15</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Ohshima, Kojima, Seneviratne and Maeda.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Ohshima, Kojima, Seneviratne and Maeda</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Candida</italic> is a major human fungal pathogen causing infectious conditions predominantly in the elderly and immunocompromised hosts. Although <italic>Candida</italic> resides as a member of the oral indigenous microbiota in symbiosis, some circumstances may cause microbial imbalance leading to dysbiosis and resultant oral candidiasis. Therefore, oral microbial symbiosis that suppresses the overgrowth of <italic>Candida</italic> is important for a healthy oral ecosystem. In this regard, probiotics, prebiotics, and synbiotics can be considered a potential therapeutic and preventive strategy against oral candidiasis. Prebiotics have a direct effect on microbial growth as they stimulate the growth of beneficial bacteria and suppress the growth of pathogens. Probiotics render a local protective effect against pathogens and a systemic indirect effect on immunological amelioration. Synbiotics are fusion products of prebiotics and probiotics. This mini review discusses the potential use and associated limitations of probiotics, prebiotics, and synbiotics for the prevention and treatment of oral candidiasis. We will also introduce biogenics, a recent concept derived from the work on probiotics. Biogenics advocates the use of beneficial bioactive substances produced by probiotic bacteria, whose activities are independent from the viability of probiotic bacteria in human bodies.</p></abstract><kwd-group><kwd>probiotics</kwd><kwd>prebiotics</kwd><kwd>synbiotics</kwd><kwd>biogenics</kwd><kwd>oral candidiasis</kwd><kwd>lactobacilli</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content></funding-source><award-id rid="cn001">24593173</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="86"/><page-count count="8"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>The indigenous microbiota on the surfaces of the skin and mucous membranes plays a role in preventing the invasion of foreign pathogenic microorganisms. The oral cavity possesses a diverse set of indigenous microbiota that perpetually interacts with the host mucosal surfaces. The oral microbiota predominantly comprises bacteria and a small proportion of fungi. <italic>Candida</italic> is the major fungus residing even in the healthy human oral cavity (<xref rid="B69" ref-type="bibr">Sardi et al., 2013</xref>). However, depending on circumstances, <italic>Candida</italic> can transform into a pathogen causing oral infections. Hence, when there is a collapse in the healthy microbial balance, i.e., dysbiosis, <italic>Candida</italic> can proliferate and cause a typical opportunistic infection. Oral candidiasis has been frequently observed in the elderly population due to problems associated with quality and the production of saliva, as well as decreased cell-mediated immunity (<xref rid="B71" ref-type="bibr">Scully et al., 1994</xref>). Systemic <italic>Candida</italic> infections such as <italic>Candida</italic> pneumonia and candidemia due to intravascular indwelling catheters have also been observed in elderly populations (<xref rid="B18" ref-type="bibr">Eggimann et al., 2003</xref>). Recurrent oral candidiasis occurs frequently in HIV-positive and AIDS patients (<xref rid="B71" ref-type="bibr">Scully et al., 1994</xref>). The administration of antifungal drugs is generally the first-line therapy of candidiasis. However, the emergence of drug-resistant strains and frequent recurrence of the disease in affected individuals are increasing challenges in antifungal therapy (<xref rid="B64" ref-type="bibr">Pfaller and Diekema, 2007</xref>). This has prompted the need for an alternative therapeutic and prevention strategy. In this mini review, we will succinctly discuss the potential use of probiotics, prebiotics, and synbiotics as an alternative antifungal therapy. In addition, a new concept of biogenics will be introduced. Biogenics is a strategy to overcome the potential disadvantage of synbiotics, including difficulties in the colonization process of non-native probiotic bacteria. It also provides an additional advantage to produce functional foods with bioactive metabolites.</p></sec><sec><title>Probiotics</title><sec><title>The Definition and History</title><p>The term &#x0201c;probiotics,&#x0201d; in contrast to antibiotics, was proposed by <xref rid="B46" ref-type="bibr">Lilly and Stillwell (1965)</xref>, from the original ecological term, &#x0201c;probiosis&#x0201d; used by <xref rid="B40" ref-type="bibr">Kollath (1953)</xref>, meaning a symbiotic relationship between organisms. <xref rid="B21" ref-type="bibr">Fuller (1989)</xref> defined a probiotic as &#x0201c;A live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance&#x0201d; (<xref rid="B21" ref-type="bibr">Fuller, 1989</xref>). Hence, at that time, probiotics were intended to be used only for the &#x0201c;intestinal microbiota.&#x0201d; Subsequent studies revealed general health benefits of probiotics, such as an enhancement of the human immune system, preventive effects concerning urinary tract and respiratory tract infections and the allergic or atopic condition in infants (<xref rid="B25" ref-type="bibr">Gourbeyre et al., 2011</xref>). Hence, probiotics were redefined by <xref rid="B68" ref-type="bibr">Salminen et al. (1998)</xref> as &#x0201c;A viable microbial food supplement which beneficially influences the health of the host.&#x0201d; According to the FAO/WHO, probiotics are defined as &#x0201c;live microorganisms when administered in adequate amounts confer a health benefit on the host&#x0201d; (<xref rid="B20" ref-type="bibr">FAO/WHO, 2001</xref>).</p></sec><sec><title>Clinical Trials of Probiotics for Oral <italic>Candida</italic> Infections</title><p>There has been a gradual increase in the number of studies that focus on the application of probiotics on oral health (<xref rid="B29" ref-type="bibr">Haukioja, 2010</xref>). The majority of these studies have focused on two major dental diseases, dental caries and periodontitis (<xref rid="B42" ref-type="bibr">Krasse et al., 2005</xref>; <xref rid="B82" ref-type="bibr">Vivekananda et al., 2010</xref>; <xref rid="B7" ref-type="bibr">Cagetti et al., 2013</xref>). However, studies on the use of probiotics for oral candidiasis are sparse (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). <xref rid="B2" ref-type="bibr">Ahola et al. (2002)</xref> and <xref rid="B28" ref-type="bibr">Hatakka et al. (2007)</xref> conducted double-blinded, randomized clinical trials using probiotic cheese on elderly populations with some oral health problems and carriers of oral <italic>Candida</italic> compared with a younger cohort (18&#x02013;35 years of age). There was an observed trend that the probiotics could decrease the quantity of <italic>Candida</italic>. However, the effect was not significant (<xref rid="B2" ref-type="bibr">Ahola et al., 2002</xref>) or was small without an improvement in the mucosal symptom (<xref rid="B28" ref-type="bibr">Hatakka et al., 2007</xref>). On the other hand, studies conducted by <xref rid="B51" ref-type="bibr">Mendon&#x000e7;a et al. (2012)</xref>, <xref rid="B32" ref-type="bibr">Ishikawa et al. (2015)</xref>, and <xref rid="B41" ref-type="bibr">Kraft-Bodi et al. (2015)</xref> reported a slight or moderate improvement of oral candidiasis when patients were treated with probiotics. <xref rid="B16" ref-type="bibr">Dos Santos et al. (2009)</xref> reported a drastic improvement of oral candidiasis upon probiotic treatment.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Summary of studies that examined the antifungal activity of probiotics against <italic>Candida albicans.</italic></p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Reference</th><th valign="top" align="left" rowspan="1" colspan="1">Test strains</th><th valign="top" align="left" rowspan="1" colspan="1">Test design/Feature tested</th><th valign="top" align="left" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Clinical studies</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B2" ref-type="bibr">Ahola et al. (2002)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. rhamnosus GG/LS</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Intervention with cheese,<break/>Double-blinded placebo RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction in the risk of a high level of <italic>Candida</italic></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B28" ref-type="bibr">Hatakka et al. (2007)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. lactis</italic>,<break/><italic>L. helveticus</italic>,<break/><italic>L. rhamnosus GG</italic>,<break/><italic>P. freudenreichii</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Intervention of an elderly group with cheese for 16 weeks, Double-blinded randomized placebo trial (tested group, <italic>n</italic> = 136, control group, <italic>n</italic> = 140)</td><td valign="top" align="left" rowspan="1" colspan="1">10% reduction of the high <italic>Candida</italic> count rate in the tested group (after 16-weeks intervention)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B16" ref-type="bibr">Dos Santos et al. (2009)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. casei.</italic><break/><italic>B. breve</italic></td><td valign="top" align="left" rowspan="1" colspan="1">No control group, 26 individuals<break/>Intervention with a commercial probiotic drink for 20 days</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of the <italic>Candida</italic> carrying rate, reduction of the sIgA level</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B51" ref-type="bibr">Mendon&#x000e7;a et al. (2012)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. casei</italic>,<break/><italic>B. breve</italic></td><td valign="top" align="left" rowspan="1" colspan="1">No control group,<break/>42 individuals over 65 years of age<break/>Intervention with a commercial probiotic drink for 30 days</td><td valign="top" align="left" rowspan="1" colspan="1">Decrement of <italic>Candida</italic> prevalence, increment of sIgA level</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B74" ref-type="bibr">Sutula et al. (2013)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. casei</italic></td><td valign="top" align="left" rowspan="1" colspan="1">No control group, 22 healthy individuals approximately 32 years of age<break/>Intervention with a commercial probiotic drink for 4 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">No reduction of the <italic>Candida</italic> CFU, reduction of the halitosis score, did not detect <italic>L. casei</italic> after tests</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B32" ref-type="bibr">Ishikawa et al. (2015)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. rhamnosus, L. acidophilus</italic>,<break/><italic>B. bifidum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Double-blinded randomized trial (tested group, <italic>n</italic> = 30, control group, <italic>n</italic> = 29)<break/>Intervention with trial probiotic products for 5 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of the <italic>Candida</italic> carrying rate in the tested group</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B41" ref-type="bibr">Kraft-Bodi et al. (2015)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. reuteri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Double-blinded placebo RCT, elderly individuals living in a nursing home (tested group, <italic>n</italic> = 84, control group, <italic>n</italic> = 90)<break/>Intervention with probiotic lozenges</td><td valign="top" align="left" rowspan="1" colspan="1">Improved the <italic>Candida</italic> score</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Animal studies</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B83" ref-type="bibr">Wagner et al. (1997)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. acidophilus</italic>,<break/><italic>L. reuteri</italic>,<break/><italic>L. casei</italic>,<break/><italic>B. animalis</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Oral candidiasis model in immunodeficient bg/bg-nu/nu mice<break/>Estimated by the CFU and pathological examinations</td><td valign="top" align="left" rowspan="1" colspan="1">Increased the life expectancy in the tested group</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B19" ref-type="bibr">Elahi et al. (2005)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. acidophilus</italic>,<break/><italic>L. fermentum</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> infection model using male DBA/2 mice (H-2d), 6&#x02013;8 weeks of age<break/>Oral administration of probiotics</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction in the duration of <italic>Candida</italic> colonization in the tested group</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B49" ref-type="bibr">Matsubara et al. (2012)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. acidophilus</italic>,<break/><italic>L. rhamnosus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">DBA/2 murine oral <italic>Candida</italic> infection model. Control group was treated with nystatin, tested group was treated with probiotics</td><td valign="top" align="left" rowspan="1" colspan="1">Reduction of the <italic>Candida</italic> level in the tested group compared with the control group</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B86" ref-type="bibr">Zavisic et al. (2012)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. plantarum</italic>,<break/><italic>L. casei</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Wister rats and NMRI Ham laboratory mice</td><td valign="top" align="left" rowspan="1" colspan="1">Did not show an inhibition in <italic>C. albicans</italic> growth</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B31" ref-type="bibr">Ishijima (2012)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>S. salivarius</italic></td><td valign="top" align="left" rowspan="1" colspan="1">ICR mice, oral candidiasis model</td><td valign="top" align="left" rowspan="1" colspan="1">Probiotics were not fungicidal, but inhibited <italic>Candida</italic> adhesion</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold><italic>In vitro</italic> test</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B12" ref-type="bibr">Chung et al. (1989)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. reuteri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">MIC assay using partial purified reuterin</td><td valign="top" align="left" rowspan="1" colspan="1">Reuterin, an anti- microbial substance with broad spectrum effects, led to the reduction of <italic>C. albicans growth</italic></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B39" ref-type="bibr">Koll et al. (2008)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. plantarum</italic>,<break/><italic>L. paracasei</italic>,<break/><italic>L. salivarius</italic>,<break/><italic>L. rhamnosus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Antimicrobial activity was detected using the antagonism method<break/></td><td valign="top" align="left" rowspan="1" colspan="1">Did not show an inhibition in <italic>C. albicans</italic> growth</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B37" ref-type="bibr">K&#x000f6;hler et al. (2012)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. rhamnosus</italic>,<break/><italic>L. reuteri</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Antimicrobial activity was detected using an overlay plate or co-culture assay.<break/>The genome-wide transcriptional profile of <italic>C. albicans</italic> was assayed with a cDNA microarray</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>C. albicans</italic> was antisepticized by inhibition of the metabolic activity under a low pH</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B27" ref-type="bibr">Hasslof et al. (2010)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. plantarum</italic>,<break/><italic>L. rhamnosus GG</italic>,<break/><italic>L. paracasei</italic>,<break/><italic>L. reuteri</italic>,<break/><italic>L. acidophilus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Agar overlay interference tests</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Candida</italic> growth was reduced, however, the effect was generally weaker than for mutans streptococci</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B35" ref-type="bibr">Jiang et al. (2014)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. rhamnosus GG, L. casei</italic>,<break/><italic>L. reuteri</italic>,<break/><italic>L. brevis</italic>,<break/><italic>L. bulgaricus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Estimated the inhibition effect by pH conditions and the combination of saccharides using EIR</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibition capacity differed in the probiotic strains, <italic>L. rhamnosus</italic> showed the strongest inhibition effects against <italic>C. albicans</italic></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B73" ref-type="bibr">Shokryazdan et al. (2014)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. acidophilus</italic>,<break/><italic>L. buchneri</italic>,<break/><italic>L. casei</italic>,<break/><italic>L. fermentum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Co-culture test with 12 pathogenic microorganisms</td><td valign="top" align="left" rowspan="1" colspan="1">The active substance was organic acid</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B36" ref-type="bibr">Kheradmand et al. (2014)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. johnsonii</italic>,<break/><italic>L.plantarum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">After selenium treatment, the antimicrobial effects improved</td><td valign="top" align="left" rowspan="1" colspan="1">The active substances were exometabolities or novel anti-<italic>Candida</italic> compounds</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B38" ref-type="bibr">Kojima et al. (2015)</xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>L. fermentum</italic>,<break/><italic>L. plantarum</italic>,<break/><italic>L. paracasei</italic> per 12 species (40 strains)</td><td valign="top" align="left" rowspan="1" colspan="1">Co-culture and growth inhibition assays of <italic>C. albicans</italic> with <italic>Lactobacilli</italic> culture supernatant or saccharides</td><td valign="top" align="left" rowspan="1" colspan="1">Three saccharides and five strains became candidates for pre- and probiotics, respectively</td></tr></tbody></table></table-wrap></sec><sec><title><italic>In Vivo</italic> Animal and <italic>In Vitro</italic> Studies of Probiotics for Oral <italic>Candida</italic> Infections</title><p>Several <italic>in vivo</italic> animal studies have been performed which have examined the effect of probiotics on oral <italic>Candida</italic> infections. However, the results remain controversial. Some reports suggested a local as well as systemic beneficial effect of probiotics on candidiasis (<xref rid="B83" ref-type="bibr">Wagner et al., 1997</xref>; <xref rid="B19" ref-type="bibr">Elahi et al., 2005</xref>; <xref rid="B49" ref-type="bibr">Matsubara et al., 2012</xref>), while others have not observed a positive effect (<xref rid="B86" ref-type="bibr">Zavisic et al., 2012</xref>). These diverse observations may result from differences in the administration technique employed. However, <xref rid="B38" ref-type="bibr">Kojima et al. (2015)</xref> demonstrated that the key factor for the effectiveness of probiotics may be the selection of an appropriate strain that works against <italic>Candida.</italic> A diverse set of <italic>Lactobacilli</italic> species has been used for the previous probiotic studies. The genome size of the <italic>Lactobacillus</italic> genus ranges from 1.23&#x02013;4.91 Mb and the GC content spans 31.9&#x02013;57.0% among different species (<xref rid="B9" ref-type="bibr">Caufield et al., 2015</xref>). In addition, the properties of strains within the same species of <italic>Lactobacillus</italic> have been shown to vary (<xref rid="B39" ref-type="bibr">Koll et al., 2008</xref>; <xref rid="B78" ref-type="bibr">Tiihonen et al., 2010</xref>). Some of these studies have selected probiotic (<italic>Lactobacillus</italic>) strains that are known to confer intestinal health benefits and presume a similar beneficial effect on oral infections or <italic>Candida</italic> infections. Therefore, it is important to demonstrate the <italic>in vitro</italic> activity of a probiotic strain against <italic>Candida</italic> and subsequently select an efficient strain for <italic>in vivo</italic> and clinical studies. Such studies are few and shown in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>.</p></sec><sec><title>Anti-<italic>Candida</italic> Products of Probiotics for Oral Candidiasis</title><p>Probiotic lactobacilli co-aggregate with <italic>Candida</italic> and produce antimicrobial substances that have a direct growth inhibitory effect on <italic>Candida</italic>. Some of these substances produced include organic acids (e.g., lactic acid and acetic acid), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), bacteriocins, and uncharacterized low molecular weight substances with antifungal properties. Lactobacilli universally produce lactic acid that inhibits the metabolic activity of <italic>Candida</italic> sp. (<xref rid="B37" ref-type="bibr">K&#x000f6;hler et al., 2012</xref>), which has a weak antifungal activity (<xref rid="B85" ref-type="bibr">Zal&#x000e1;n et al., 2010</xref>). It appears that lactobacilli do not produce effective concentrations of H<sub>2</sub>O<sub>2</sub> against fungi (<xref rid="B73" ref-type="bibr">Shokryazdan et al., 2014</xref>), unlike other bacteria (<xref rid="B65" ref-type="bibr">Piard and Desmazeaud, 1991</xref>).</p><p>Lactic acid bacteria produce bacteriocins, proteinaceous antimicrobial substances with molecular weights of several thousand daltons or more. Bacteriocins can be divided into five classes according to their primary structure, molecular composition and properties (<xref rid="B10" ref-type="bibr">Chen and Hoover, 2003</xref>; <xref rid="B63" ref-type="bibr">Pascual et al., 2008</xref>). Bacteriocin L23 produced by <italic>Lactobacillus fermentum</italic> L23 (<xref rid="B63" ref-type="bibr">Pascual et al., 2008</xref>), plantaricin produced by <italic>L. plantarum</italic> (<xref rid="B72" ref-type="bibr">Sharma and Srivastava, 2014</xref>), and pentocin TV35b produced by <italic>L. pentosus</italic> (<xref rid="B59" ref-type="bibr">Okkers et al., 1999</xref>) appear to be effective against the yeast form of <italic>Candida</italic>. Bacteriocins effective for hyphal forms of <italic>Candida</italic> have not yet been identified (<xref rid="B8" ref-type="bibr">Calderone and Fonzi, 2001</xref>; <xref rid="B17" ref-type="bibr">Douglas, 2003</xref>). Low molecular substances of lactobacilli, such as reuterin (<xref rid="B76" ref-type="bibr">Talarico et al., 1988</xref>), reutericyclin (<xref rid="B22" ref-type="bibr">Ganzle, 2000</xref>), and dyacetyl (<xref rid="B33" ref-type="bibr">Jay, 1982</xref>), have also been shown to be effective against the yeast forms of <italic>Candida</italic> (<xref rid="B12" ref-type="bibr">Chung et al., 1989</xref>).</p></sec></sec><sec><title>Prebiotics</title><p>The term &#x0201c;prebiotics&#x0201d; was defined by <xref rid="B23" ref-type="bibr">Gibson and Roberfroid (1995)</xref> as &#x0201c;a non-digestible food ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, and thus improves host health.&#x0201d; Studies of oral prebiotics are limited. Sugars and dietary fiber have been considered to be prebiotics for intestinal lactic acid bacteria (<xref rid="B23" ref-type="bibr">Gibson and Roberfroid, 1995</xref>). However, this is not the case for the oral environment, as the presence of sugars increases the risk of dental caries. The mutans group of streptococci metabolizes cariogenic sugars, such as glucose and sucrose, and produces organic acid and insoluble glucan factors that contribute to dental caries. On the other hand, sugar alcohols such as xylitol suppress the growth of <italic>Streptococcus mutans</italic>. Xylitol, a reduced derivative of xylose, converts to xylitol-5-phosphate inside <italic>S. mutans</italic> cells and inhibits glycolysis (<xref rid="B55" ref-type="bibr">Miyasawa-Hori et al., 2006</xref>). Similarly, arabinose, a member of the same aldopentose group as xylose, is not assimilated by <italic>S. mutans</italic> (<xref rid="B13" ref-type="bibr">Coykendall, 1977</xref>) and likely has a similar effect as xylitol. We recently demonstrated that xylitol, xylose, and arabinose inhibited the growth of <italic>S. mutans</italic>, but were utilized for the growth of most of the lactobacilli strains we tested (<xref rid="B38" ref-type="bibr">Kojima et al., 2015</xref>). Although xylitol is generally not assimilated by lactobacilli, a recent report showed that 36% of lactobacilli strains isolated from human oral cavities were able to metabolize xylitol (<xref rid="B3" ref-type="bibr">Almstahl et al., 2013</xref>). Meanwhile, our previous data on <italic>Candida albicans</italic> ATCC18804 showed decreased growth in the presence of three saccharides (xylitol, xylose, and arabinose) compared with glucose (<xref rid="B38" ref-type="bibr">Kojima et al., 2015</xref>). There are conflicting reports on the ability of <italic>C. albicans</italic> to assimilate xylitol and aldopentose. <xref rid="B47" ref-type="bibr">M&#x000e4;kinen et al. (1975)</xref> and <xref rid="B48" ref-type="bibr">Maleszka and Schneider (1982)</xref> showed that <italic>C. albicans</italic> is not capable of proper growth in the presence of xylitol. <xref rid="B79" ref-type="bibr">Uittamo et al. (2011)</xref> suggested that xylitol metabolism of <italic>Candida</italic> might compete for the nicotinamide adenine dinucleotide (NADH) coenzyme, leading to the downregulation of alcohol dehydrogenase (ADH). Clinical trials of Turku sugar studies III and VIII showed significantly decreased colony counts and detection frequency of oral <italic>Candida</italic> in the xylitol intake group [<xref rid="B43" ref-type="bibr">Larmas et al. (1974</xref>, <xref rid="B44" ref-type="bibr">1976</xref>)]. On the other hand, yeast is known to possess a pentose assimilation pathway that produces ethanol from arabinose and xylose by an enzymatic reaction (<xref rid="B11" ref-type="bibr">Chiang and Knight, 1960</xref>; <xref rid="B60" ref-type="bibr">&#x000d4;nishi and Suzuki, 1966</xref>). Even if <italic>Candida</italic> is capable of slowly assimilating those three candidate sugars, the phenomenon of slower growth compared to that of probiotic bacteria may have a competitive inhibition on <italic>Candida</italic>. The presence of xylitol inhibits the adhesion of <italic>Candida</italic> to mucosal surfaces (<xref rid="B66" ref-type="bibr">Pizzo et al., 2000</xref>; <xref rid="B1" ref-type="bibr">Abu-Elteen, 2005</xref>). In an experimental murine model of gastrointestinal candidiasis, the colonization and invasion of <italic>C. albicans</italic> was significantly reduced in the group supplemented with xylitol compared to the group supplemented with glucose (<xref rid="B81" ref-type="bibr">Vargas et al., 1993</xref>).</p></sec><sec><title>Synbiotics</title><sec><title>The Noteworthy Features of Synbiotics Associated with the Oral Application</title><p><xref rid="B23" ref-type="bibr">Gibson and Roberfroid (1995)</xref> proposed the use of probiotics and prebiotics fusion products or &#x0201c;synbiotics&#x0201d; for the intestinal tract microbiota (<xref rid="B62" ref-type="bibr">Panigrahi et al., 2008</xref>). However, the use of synbiotics for the oral microbiota has not been well studied (<xref rid="B38" ref-type="bibr">Kojima et al., 2015</xref>). It is important to understand the limitations associated with the oral application of synbiotics. Probiotic bacteria are not able to easily colonize adult oral cavities (<xref rid="B45" ref-type="bibr">Lazarevic et al., 2010</xref>; <xref rid="B78" ref-type="bibr">Tiihonen et al., 2010</xref>). Therefore, it appears that synbiotics are more effective for oral applications than probiotics alone. One must, however, consider the risk of dental caries while applying lactic acid bacteria in the oral cavity. Lactobacilli have long been considered to be one of the cariogenic bacteria present in dental plaque (<xref rid="B24" ref-type="bibr">Glass, 1952</xref>). Currently, there are two concepts on the association of lactobacilli with dental caries. Lactobacilli comprise a very small proportion of normal oral microbiota and are primarily present on the tongue dorsum, rather than in dental plaque (<xref rid="B80" ref-type="bibr">van Houte et al., 1972</xref>). However, they are hardly detected in the oral cavity of caries-free individuals (<xref rid="B84" ref-type="bibr">Yang et al., 2010</xref>). The lactobacilli count in the saliva is an indicator of the dental caries activity as lactobacilli penetrate porous tooth surfaces in early caries lesions or adhere to type I collagen exposed in the carious portion of the tooth (<xref rid="B9" ref-type="bibr">Caufield et al., 2015</xref>). As the salivary lactobacilli count correlates with the amount and frequency of carbohydrate (sugar) intake (<xref rid="B34" ref-type="bibr">Jay, 1947</xref>; <xref rid="B5" ref-type="bibr">Becks, 1950</xref>), the presence of lactobacilli is a reliable indicator for the dental caries activity (<xref rid="B14" ref-type="bibr">Crossner, 1981</xref>). Therefore, if one can maintain good oral hygiene, oral probiotic therapy with lactobacilli alone may not contribute to the development of dental caries. In addition, if appropriate prebiotics are administered simultaneously, then synbiotic therapy may suppress the development of oral candidiasis.</p></sec><sec><title>The Different Immune Responses Associated with Synbiotics in the Intestinal Tracts or Oral Cavities</title><p>The important considerations for synbiotic therapy of the intestine and oral cavity are the host immune component and reactions. While activation of a substantial host immune response can be expected in the intestine, a similar phenomenon is not expected in the oral cavity as it is not an organ of mucosa-associated lymphoid tissues (MALT). In the intestine, probiotic bacteria are incorporated into M cells in Peyer&#x02019;s patches (PP), which is a major component of gut-associated lymphoid tissues (GALT), and digested to form active antigens. Macrophages and dendritic cells in PP phagocytize probiotic bacteria and are activated to produce several cytokines, which stimulate T-cell and B-cell functions (<xref rid="B50" ref-type="bibr">Matsuzaki et al., 2007</xref>). Moreover, daily supplementation of lactobacilli as part of a normal diet increased the number and activity of natural killer cells in healthy elderly individuals (<xref rid="B78" ref-type="bibr">Tiihonen et al., 2010</xref>). Thus, synbiotics in the intestinal tract can be expected to activate both innate immunity and acquired immunity of cell-mediated and humoral immunity. Conversely, the oral cavity it is not an immune organ and phenomenon such as direct antigen presentation to adaptive immune cells does not occur. Nevertheless, some probiotic clinical trials and animal studies using oral candidiasis models have reported an increase of sIgA against <italic>Candida</italic>, leading to the suppression of <italic>Candida</italic> in the oral cavity (<xref rid="B83" ref-type="bibr">Wagner et al., 1997</xref>; <xref rid="B19" ref-type="bibr">Elahi et al., 2005</xref>; <xref rid="B51" ref-type="bibr">Mendon&#x000e7;a et al., 2012</xref>). It is well known that secretion of sIgA at the salivary gland is through differentiated plasma cells from B cells stimulated at MALT. According to the results of clinical and animal studies described above, oral synbiotics appear to transition into intestinal synbiotics, as the oral cavity is connected to the intestine. Children who were oral lactobacilli carriers were found to have similar lactobacilli in their feces (<xref rid="B9" ref-type="bibr">Caufield et al., 2015</xref>). Hence, it appears that the intestinal colonization of lactobacilli is transmitted though the oral cavity, which may provide simultaneous synbiotic activity at the oral cavity and the intestine.</p></sec></sec><sec><title>Biogenics</title><p>Previous studies have highlighted the limitation of colonization and fixation of non-nature probiotic bacteria in the intestinal tracts of human bodies (<xref rid="B26" ref-type="bibr">Haenel, 1960</xref>; <xref rid="B54" ref-type="bibr">Mitsuoka and Kaneuchi, 1977</xref>). This scenario is also relevant for the probiotic application in oral cavities, particularly when considering the associated risk of oral probiotics and dental caries. In order to address foregoing concerns, the concept of &#x0201c;biogenics&#x0201d; has been suggested as a solution (<xref rid="B52" ref-type="bibr">Mitsuoka, 2000</xref>). Biogenics is defined as &#x0201c;food ingredients which beneficially affect the host by directly immunostimulating or suppressing mutagenesis, tumorigenesis, peroxidation, hypercholesterolemia, or intestinal putrefaction&#x0201d; (<xref rid="B52" ref-type="bibr">Mitsuoka, 2000</xref>). Hence, previous studies have suggested the administration of non-viable probiotic bacteria to obtain some &#x0201c;probiotic&#x0201d; effects. It was reported that the consumption of pasteurized fermented milk elongated the lifespan of mice (<xref rid="B4" ref-type="bibr">Arai et al., 1980</xref>; <xref rid="B75" ref-type="bibr">Takano et al., 1985</xref>). A significant reduction of the Ehrlich ascites tumor growth in mice was also reported (<xref rid="B75" ref-type="bibr">Takano et al., 1985</xref>). In addition, it was shown that heat-inactivated <italic>Enterococcus faecalis</italic> (<xref rid="B77" ref-type="bibr">Terada et al., 2004</xref>) or <italic>L. gasseri</italic> (<xref rid="B70" ref-type="bibr">Sawada et al., 2016</xref>) retained a beneficial regulatory function in the gut. Moreover, <xref rid="B58" ref-type="bibr">Nakamura et al. (1995)</xref> identified an angiotensin I-converting enzyme (ACE) inhibitor in a Japanese sterilized milk beverage fermented by <italic>L. helveticus</italic> and <italic>Saccharomyces cerevisiae.</italic> The active substance was lactotripeptides metabolically generated in the fermentation pathway. Follow-up studies were able to determine the bioactive metabolites of probiotic bacteria in addition to the antimicrobial substances, such as bacteriocin (<xref rid="B67" ref-type="bibr">Ross et al., 2010</xref>; <xref rid="B61" ref-type="bibr">O&#x02019;Shea et al., 2012</xref>), and other beneficial active substances, such as conjugated linoleic acid (CLA; <xref rid="B30" ref-type="bibr">Hayes et al., 2006</xref>; <xref rid="B67" ref-type="bibr">Ross et al., 2010</xref>; <xref rid="B61" ref-type="bibr">O&#x02019;Shea et al., 2012</xref>), protein or peptides (<xref rid="B56" ref-type="bibr">M&#x000f6;ller et al., 2008</xref>; <xref rid="B6" ref-type="bibr">Bogsan et al., 2013</xref>), and polyphenols (<xref rid="B15" ref-type="bibr">Dharmaraj, 2010</xref>; <xref rid="B57" ref-type="bibr">Monagas et al., 2010</xref>). Taking all these observations into account, the new concept, biogenics, which makes use of the bioactive metabolites as foods or medicine, was recently advocated (<xref rid="B52" ref-type="bibr">Mitsuoka, 2000</xref>, <xref rid="B53" ref-type="bibr">2014</xref>). The biogenics effect is independent of the colonization and viability of probiotic bacteria. Hence, biogenics is the direct delivery of an isolated and purified active ingredient of probiotics to the local environment. This strategy may also be used as an antifungal therapy. It may be possible to purify the active ingredients of probiotic bacteria that demonstrate antifungal activity for use in the biogenics process. However, this idea requires further study before clinical use.</p></sec><sec><title>Conclusion</title><p>Taking the abovementioned studies into consideration, it is conceivable that an innovative combination of prebiotics, probiotics, synbiotics, and biogenics instrumental in devising a successful, novel antifungal regime in the future (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). More comprehensive investigations on the mechanism of synbiotics and biogenics are needed for this purpose. Hence, more studies are warranted to examine the bioactive metabolites of probiotic bacteria that induce favorable immunological outcomes and suppress <italic>Candida</italic> infection in the human oral cavity.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p><bold>Anti-<italic>Candida</italic> effects with synchronized prebiotics, probiotics, biogenics, and immunological resistance</bold>.</p></caption><graphic xlink:href="fmicb-07-00010-g001"/></fig></sec><sec><title>Author Contributions</title><p>TO made the description plan of this review article, and carried out the manuscript writing and figure charting. YK, CS, and NM read carefully and made arrangements on the manuscript according their discussions.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>A part of this work was funded by the Japan Society for the Promotion of Science: KAKENHI(C) (No. 24593173 to TO).</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Elteen</surname><given-names>K. H.</given-names></name></person-group> (<year>2005</year>). <article-title>The influence of dietary carbohydrates on in vitro adherence of four <italic>Candida species</italic> to human buccal epithelial cells.</article-title>
<source><italic>Microbiol. Ecol. Health Dis.</italic></source>
<volume>17</volume>
<fpage>156</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1080/08910600500442917</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahola</surname><given-names>A. J.</given-names></name><name><surname>Yli-Knuuttila</surname><given-names>H.</given-names></name><name><surname>Suomalainen</surname><given-names>T.</given-names></name><name><surname>Poussa</surname><given-names>T.</given-names></name><name><surname>Ahlstr&#x000f6;m</surname><given-names>A.</given-names></name><name><surname>Meurman</surname><given-names>J. H.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factor.</article-title>
<source><italic>Arch. Oral Biol.</italic></source>
<volume>47</volume>
<fpage>799</fpage>&#x02013;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1016/S0003-9969(02)00112-7</pub-id><pub-id pub-id-type="pmid">12446187</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almstahl</surname><given-names>A.</given-names></name><name><surname>Lingstrom</surname><given-names>P.</given-names></name><name><surname>Eliasson</surname><given-names>L.</given-names></name><name><surname>Carlen</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Fermentation of sugars and sugar alcohols by plaque <italic>Lactobacillus strains</italic>.</article-title>
<source><italic>Clin. Oral. Investig.</italic></source>
<volume>17</volume>
<fpage>1465</fpage>&#x02013;<lpage>1470</lpage>. <pub-id pub-id-type="doi">10.1007/s00784-012-0832-z</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>K.</given-names></name><name><surname>Murota</surname><given-names>I.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Kataoka</surname><given-names>M.</given-names></name><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>1980</year>). <article-title>Effects of administration of pasteurized fermented milk to mice on the life-span and intestinal flora.</article-title>
<source><italic>J. Jpn. Soc. Nutr. Food. Sci.</italic></source>
<volume>33</volume>
<fpage>219</fpage>&#x02013;<lpage>223</lpage>.</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becks</surname><given-names>H.</given-names></name></person-group> (<year>1950</year>). <article-title>Carbohydrate restriction in the prevention of dental caries using the LA count as one index.</article-title>
<source><italic>J. CA Dent. Assoc.</italic></source>
<volume>26</volume>
<fpage>53</fpage>&#x02013;<lpage>58</lpage>.</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogsan</surname><given-names>C. S.</given-names></name><name><surname>Florence</surname><given-names>A. C. R.</given-names></name><name><surname>Perina</surname><given-names>N.</given-names></name><name><surname>Hirota</surname><given-names>C.</given-names></name><name><surname>Soares</surname><given-names>F. A. S. M.</given-names></name><name><surname>Silva</surname><given-names>R. C.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Survival of <italic>Bifidobacterium lactis</italic> HN019 and release of biogenic compounds in unfermented and fermented milk is affected by chilled storage at 4&#x000b0;C.</article-title>
<source><italic>J. Prob. Health</italic></source>
<volume>4</volume>:<issue>114</issue>
<pub-id pub-id-type="doi">10.4172/2329-8901.1000114</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagetti</surname><given-names>M. G.</given-names></name><name><surname>Mastroberardino</surname><given-names>S.</given-names></name><name><surname>Milia</surname><given-names>E.</given-names></name><name><surname>Cocco</surname><given-names>F.</given-names></name><name><surname>Lingstr&#x000f6;m</surname><given-names>P.</given-names></name><name><surname>Campus</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>The use of probiotic strains in caries prevention: a systematic review.</article-title>
<source><italic>Nutrients</italic></source>
<volume>5</volume>
<fpage>2530</fpage>&#x02013;<lpage>2550</lpage>. <pub-id pub-id-type="doi">10.3390/nu5072530</pub-id><pub-id pub-id-type="pmid">23857225</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calderone</surname><given-names>R. A.</given-names></name><name><surname>Fonzi</surname><given-names>W. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Virulence factors of <italic>Candida albicans</italic>.</article-title>
<source><italic>Trends Microbiol.</italic></source>
<volume>9</volume>
<fpage>327</fpage>&#x02013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/S0966-842X(01)02094-7</pub-id><pub-id pub-id-type="pmid">11435107</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caufield</surname><given-names>P. W.</given-names></name><name><surname>Sch&#x000f6;n</surname><given-names>C. N.</given-names></name><name><surname>Saraithong</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Argim&#x000f3;n</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Oral lactobacilli and dental caries : a model for niche adaptation in humans.</article-title>
<source><italic>J. Dental. Res.</italic></source>
<volume>94(9 Suppl.)</volume>
<fpage>110S</fpage>&#x02013;<lpage>118S</lpage>. <pub-id pub-id-type="doi">10.1177/0022034515576052</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Hoover</surname><given-names>D. G.</given-names></name></person-group> (<year>2003</year>). <article-title>Bacteriocins and their food applications.</article-title>
<source><italic>Compr. Rev. Food Sci. Food Saf.</italic></source>
<volume>2</volume>
<fpage>82</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1111/j.1541-4337.2003.tb00016.x</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>C.</given-names></name><name><surname>Knight</surname><given-names>S. G.</given-names></name></person-group> (<year>1960</year>). <article-title>A new pathway of pentose metabolism.</article-title>
<source><italic>Biochem. Biophys. Res. Commun.</italic></source>
<volume>3</volume>
<fpage>554</fpage>&#x02013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/0006-291X(60)90174-1</pub-id><pub-id pub-id-type="pmid">13692998</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>T. C.</given-names></name><name><surname>Axelsson</surname><given-names>L.</given-names></name><name><surname>Lindgren</surname><given-names>S. E.</given-names></name><name><surname>Dobrogosz</surname><given-names>W. J.</given-names></name></person-group> (<year>1989</year>). <article-title>In vitro studies on reuterin synthesis by <italic>Lactobacillus reuteri</italic>.</article-title>
<source><italic>Microbial. Ecol. Health Disease.</italic></source>
<volume>2</volume>
<fpage>137</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0037116</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coykendall</surname><given-names>A. L.</given-names></name></person-group> (<year>1977</year>). <article-title>Proposal to elevate the subspecies of <italic>Streptococcus mutans</italic> to species status, based on their molecular composition.</article-title>
<source><italic>Int. J. Syst. Evol. Microbiol.</italic></source>
<volume>27</volume>
<fpage>26</fpage>&#x02013;<lpage>30</lpage>.</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossner</surname><given-names>C. G.</given-names></name></person-group> (<year>1981</year>). <article-title>Salivary lactobacillus counts in the prediction of caries activity.</article-title>
<source><italic>Commun. Dent. Oral. Epidemiol.</italic></source>
<volume>9</volume>
<fpage>182</fpage>&#x02013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0528.1981.tb01052.x</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharmaraj</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Marine <italic>Streptomyces</italic> as a novel source of bioactive substances.</article-title>
<source><italic>World J. Microbiol. Biotechnol.</italic></source>
<volume>26</volume>
<fpage>2123</fpage>&#x02013;<lpage>2139</lpage>. <pub-id pub-id-type="doi">10.1139/cjm-2013-0785</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A. L.</given-names></name><name><surname>Jorge</surname><given-names>A. O.</given-names></name><name><surname>dos Santos</surname><given-names>S. S.</given-names></name><name><surname>Silva</surname><given-names>C. R.</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>M. V.</given-names></name></person-group> (<year>2009</year>). <article-title>Influence of probiotics on <italic>Candida</italic> presence and IgA anti-<italic>Candida</italic> in the oral cavity.</article-title>
<source><italic>Braz. J. Microbiol.</italic></source>
<volume>40</volume>
<fpage>960</fpage>&#x02013;<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1590/S1517-838220090004000030</pub-id><pub-id pub-id-type="pmid">24031447</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>L. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Candida biofilm and their role in infection.</article-title>
<source><italic>Trends Microbiol.</italic></source>
<volume>11</volume>
<fpage>30</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/S0966-842X(02)00002-1</pub-id><pub-id pub-id-type="pmid">12526852</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggimann</surname><given-names>P.</given-names></name><name><surname>Garbino</surname><given-names>J.</given-names></name><name><surname>Pittet</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>Epidemiology of <italic>Candida species</italic> infections in critically ill non-immunosuppressed patients.</article-title>
<source><italic>Lancet Infect. Dis.</italic></source>
<volume>3</volume>
<fpage>685</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(03)00831-4</pub-id><pub-id pub-id-type="pmid">14592598</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elahi</surname><given-names>S.</given-names></name><name><surname>Pang</surname><given-names>G.</given-names></name><name><surname>Ashman</surname><given-names>R.</given-names></name><name><surname>Clancy</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Enhanced clearance of <italic>Candida albicans</italic> from the oral cavities of mice following oral administration of <italic>Lactobacillus acidophilus</italic>.</article-title>
<source><italic>Clin. Exp. Immunol.</italic></source>
<volume>141</volume>
<fpage>29</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02811.x</pub-id><pub-id pub-id-type="pmid">15958067</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><collab>FAO/WHO</collab> (<year>2001</year>). <source><italic>Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation</italic>.</source> Available at: <ext-link ext-link-type="uri" xlink:href="http://www.fao.org/es/ESN/food/foodandfoo_probio_en.stm">http://www.fao.org/es/ESN/food/foodandfoo_probio_en.stm</ext-link></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>R.</given-names></name></person-group> (<year>1989</year>). <article-title>Probiotics in man and animals.</article-title>
<source><italic>J. Appl. Bacteriol.</italic></source>
<volume>66</volume>
<fpage>365</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.1989.tb05105.x</pub-id><pub-id pub-id-type="pmid">2666378</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganzle</surname><given-names>M. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Characterization of reutericyclin produced by <italic>Lactobacillus reuteri</italic> LTH2584.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>66</volume>
<fpage>4325</fpage>&#x02013;<lpage>4333</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.66.10.4325-4333.2000</pub-id><pub-id pub-id-type="pmid">11010877</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>G. R.</given-names></name><name><surname>Roberfroid</surname><given-names>M. B.</given-names></name></person-group> (<year>1995</year>). <article-title>Dietary modulation of the human colonic microbiota: introducting the concept of prebiotics.</article-title>
<source><italic>J. Nutr.</italic></source>
<volume>125</volume>
<fpage>1401</fpage>&#x02013;<lpage>1412</lpage>.<pub-id pub-id-type="pmid">7782892</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>R. L.</given-names></name></person-group> (<year>1952</year>). <article-title>The lack of relationship between salivary lactobacillus counts and dental caries activity.</article-title>
<source><italic>Oral. Surg. Oral. Med. Oral. Pathol.</italic></source>
<volume>5</volume>
<fpage>210</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/0030-4220(52)90036-4</pub-id><pub-id pub-id-type="pmid">14891215</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourbeyre</surname><given-names>P.</given-names></name><name><surname>Denery</surname><given-names>S.</given-names></name><name><surname>Bodinier</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions.</article-title>
<source><italic>J. Leukocyte Boil.</italic></source>
<volume>89</volume>
<fpage>685</fpage>&#x02013;<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1109753</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haenel</surname><given-names>H.</given-names></name></person-group> (<year>1960</year>). <article-title>Aspekte der mikro&#x000f6;kologischen beziehungen des makroorganismus. Mikroorganismen im menschlichen und tierischen darm und in anderen organen.</article-title>
<source><italic>Zentralbl. Bakteriol. Abt.</italic></source>
<volume>176</volume>
<fpage>305</fpage>&#x02013;<lpage>426</lpage>.</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasslof</surname><given-names>P.</given-names></name><name><surname>Hedberg</surname><given-names>M.</given-names></name><name><surname>Twetman</surname><given-names>S.</given-names></name><name><surname>Stecksen-Blicks</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli &#x02013; an in vitro study.</article-title>
<source><italic>BMC Oral Health</italic></source>
<volume>10</volume>:<issue>18</issue>
<pub-id pub-id-type="doi">10.1186/1472-6831-10-18</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakka</surname><given-names>K.</given-names></name><name><surname>Ahola</surname><given-names>A. J.</given-names></name><name><surname>Yli-Knuuttila</surname><given-names>H.</given-names></name><name><surname>Richardson</surname><given-names>M.</given-names></name><name><surname>Poussa</surname><given-names>T.</given-names></name><name><surname>Meurman</surname><given-names>J. H.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Probiotics reduce the prevalence of oral candida in the elderly &#x02013; a ransomized controlled trial.</article-title>
<source><italic>J. Dent. Res.</italic></source>
<volume>86</volume>
<fpage>125</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1177/154405910708600204</pub-id><pub-id pub-id-type="pmid">17251510</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haukioja</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Probiotics and oral health.</article-title>
<source><italic>Eur. J. Dent.</italic></source>
<volume>4</volume>
<fpage>348</fpage>&#x02013;<lpage>355</lpage>.<pub-id pub-id-type="pmid">20613927</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>M.</given-names></name><name><surname>Coakley</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>L.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Cheese as a delivery vehicle for probiotics and biogenic substances.</article-title>
<source><italic>Austr. J. Dairy Technol.</italic></source>
<volume>61</volume>:<issue>132</issue>.</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishijima</surname><given-names>S. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Effect of <italic>Streptococcus salivarius</italic> K12 on the in vitro growth of <italic>Candida albicans</italic> and its protective effect in an oral candidiasis model.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>78</volume>
<fpage>2190</fpage>&#x02013;<lpage>2199</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.07055-11</pub-id><pub-id pub-id-type="pmid">22267663</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>K. H.</given-names></name><name><surname>Mayer</surname><given-names>M. P.</given-names></name><name><surname>Miyazima</surname><given-names>T. Y.</given-names></name><name><surname>Matsubara</surname><given-names>V. H.</given-names></name><name><surname>Silva</surname><given-names>E. G.</given-names></name><name><surname>Paula</surname><given-names>C. R.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A multispecies probiotics reduces oral candida colonization in denture wearers.</article-title>
<source><italic>J. Prosthodontics</italic></source>
<volume>24</volume>
<fpage>194</fpage>&#x02013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1111/jopr.12198</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>J. M.</given-names></name></person-group> (<year>1982</year>). <article-title>Antimicrobial properties of diacetyl.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>44</volume>
<fpage>525</fpage>&#x02013;<lpage>532</lpage>.<pub-id pub-id-type="pmid">7137998</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>P.</given-names></name></person-group> (<year>1947</year>). <article-title>The reduction of oral <italic>Lactobacillus acidophilus</italic> counts by the periodic restriction of carbohydrate.</article-title>
<source><italic>Am. J. Orthod.</italic></source>
<volume>33</volume>
<fpage>B162</fpage>&#x02013;<lpage>B184</lpage>.</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Stamatova</surname><given-names>I.</given-names></name><name><surname>Kari</surname><given-names>K.</given-names></name><name><surname>Meurman</surname><given-names>J. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibitory activity in virto of probiotic lactobacilli against oral <italic>Candida</italic> under different fermentation conditions.</article-title>
<source><italic>Benef. Microbes</italic></source>
<volume>6</volume>
<fpage>361</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.3920/BM2014.0054</pub-id><pub-id pub-id-type="pmid">25380800</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheradmand</surname><given-names>E.</given-names></name><name><surname>Rafii</surname><given-names>F.</given-names></name><name><surname>Yazdi</surname><given-names>M. H.</given-names></name><name><surname>Sepahi</surname><given-names>A. A.</given-names></name><name><surname>Shahverdi</surname><given-names>A. R.</given-names></name><name><surname>Oveisi</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>The antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against <italic>Candida albicans</italic>.</article-title>
<source><italic>DARU</italic></source>
<volume>22</volume>:<issue>48</issue>
<pub-id pub-id-type="doi">10.1186/2008-2231-22-48</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>G. A.</given-names></name><name><surname>Assefa</surname><given-names>S.</given-names></name><name><surname>Reid</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Probiotic interference of <italic>Lactobacillus rhamnosus</italic> GR-1 and <italic>Lactobacillus reuteri</italic> RC-14 with the opportunistic fungal pathogen <italic>Candidsa albicans</italic>.</article-title>
<source><italic>Infect. Dis. Obterics Gynecol.</italic></source>
<volume>118</volume>
<fpage>1180</fpage>&#x02013;<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1155/2012/636474</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>Y.</given-names></name><name><surname>Ohshima</surname><given-names>T.</given-names></name><name><surname>Seneviratne</surname><given-names>C. J.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Combining prebiotics and probiotics to develop novel synbiotics that suppress oral pathogens.</article-title>
<source><italic>J. Oral Biosci.</italic></source>
<comment>(in press)</comment>
<pub-id pub-id-type="doi">10.1016/j.job.2015.08.004</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koll</surname><given-names>P.</given-names></name><name><surname>Mandar</surname><given-names>R.</given-names></name><name><surname>Marcotte</surname><given-names>H.</given-names></name><name><surname>Leibur</surname><given-names>E.</given-names></name><name><surname>Mikelsaar</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Characterization of oral lactobacilli as potential probiotics for oral health.</article-title>
<source><italic>Oral Microbiol. Immunol.</italic></source>
<volume>23</volume>
<fpage>139</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-302X.2007.00402.x</pub-id><pub-id pub-id-type="pmid">18279182</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kollath</surname><given-names>W.</given-names></name></person-group> (<year>1953</year>). <article-title>Ernahrung und zahnsystem (Nutrition and the tooth system).</article-title>
<source><italic>Dtsch. Zahnarztl. Z.</italic></source>
<volume>8</volume>
<fpage>7</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">13068115</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraft-Bodi</surname><given-names>E.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>M. R.</given-names></name><name><surname>Keller</surname><given-names>M. K.</given-names></name><name><surname>Kragelund</surname><given-names>C.</given-names></name><name><surname>Twetman</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of probiotic bacteria on oral candida in frail elderly.</article-title>
<source><italic>J. Dent. Res.</italic></source>
<volume>94</volume>
<fpage>181</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1177/0022034515595950</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasse</surname><given-names>P.</given-names></name><name><surname>Carlsson</surname><given-names>B.</given-names></name><name><surname>Dahl</surname><given-names>C.</given-names></name><name><surname>Paulsson</surname><given-names>A.</given-names></name><name><surname>Nilsson</surname><given-names>A.</given-names></name><name><surname>Sinkiewicz</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Decreased gum bleeding and reduced gingivitis by the probiotic <italic>Lactobacillus reuteri</italic>.</article-title>
<source><italic>Swed. Dental J.</italic></source>
<volume>30</volume>
<fpage>55</fpage>&#x02013;<lpage>60</lpage>.</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larmas</surname><given-names>M.</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>K. K.</given-names></name><name><surname>Scheinin</surname><given-names>A.</given-names></name></person-group> (<year>1974</year>). <article-title>Turku sugar studies III. An intermediate report on the effect of sucrose, fructose and xylitol diets on the numbers of salivary lactobacilli, Candida and streptococci.</article-title>
<source><italic>Acta Odontol. Scand.</italic></source>
<volume>32</volume>
<fpage>423</fpage>&#x02013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.3109/00016357409026551</pub-id><pub-id pub-id-type="pmid">4618417</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larmas</surname><given-names>M.</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>K. K.</given-names></name><name><surname>Scheinin</surname><given-names>A.</given-names></name></person-group> (<year>1976</year>). <article-title>Turku sugar studies VIII: principal microbiological findings.</article-title>
<source><italic>Acta Odontol. Scand.</italic></source>
<volume>34</volume>
<fpage>285</fpage>&#x02013;<lpage>328</lpage>. <pub-id pub-id-type="doi">10.3109/00016357609004644</pub-id><pub-id pub-id-type="pmid">1070216</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarevic</surname><given-names>V.</given-names></name><name><surname>Whiteson</surname><given-names>K.</given-names></name><name><surname>Hernandez</surname><given-names>D.</given-names></name><name><surname>Fran&#x000e7;ois</surname><given-names>P.</given-names></name><name><surname>Schrenzel</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Study of inter-and intra-individual variations in the salivary microbiota.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>11</volume>:<issue>523</issue>
<pub-id pub-id-type="doi">10.1186/1471-2164-11-523</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilly</surname><given-names>D. M.</given-names></name><name><surname>Stillwell</surname><given-names>R. H.</given-names></name></person-group> (<year>1965</year>). <article-title>Probiotics growth promoting factors produced by micro-organisms.</article-title>
<source><italic>Science</italic></source>
<volume>147</volume>
<fpage>747</fpage>&#x02013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1126/science.147.3659.747</pub-id><pub-id pub-id-type="pmid">14242024</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e4;kinen</surname><given-names>K. K.</given-names></name><name><surname>Ojanotko</surname><given-names>A.</given-names></name><name><surname>Vidgren</surname><given-names>H.</given-names></name></person-group> (<year>1975</year>). <article-title>Effect of xylitol on the growth of three oral strains of <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Dent. Res.</italic></source>
<volume>54</volume>
<fpage>1239</fpage>&#x02013;<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.1177/00220345750540062901</pub-id><pub-id pub-id-type="pmid">1104677</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maleszka</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>H.</given-names></name></person-group> (<year>1982</year>). <article-title>Fermentation of D-xylose, xylitol, and D-xylulose by yeasts.</article-title>
<source><italic>Can. J. Microbiol.</italic></source>
<volume>28</volume>
<fpage>360</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1139/m82-054</pub-id><pub-id pub-id-type="pmid">6211222</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsubara</surname><given-names>V. H.</given-names></name><name><surname>Silva</surname><given-names>E. G.</given-names></name><name><surname>Paula</surname><given-names>C. R.</given-names></name><name><surname>Ishikawa</surname><given-names>K. H.</given-names></name><name><surname>Nakamae</surname><given-names>A. E. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Treatment with probiotics in experimental oral colonization by <italic>Candida albicans</italic> in murine model (DBA/2).</article-title>
<source><italic>Oral Dis.</italic></source>
<volume>18</volume>
<fpage>260</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-0825.2011.01868.x</pub-id><pub-id pub-id-type="pmid">22059932</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>T.</given-names></name><name><surname>Takagi</surname><given-names>A.</given-names></name><name><surname>Ikemura</surname><given-names>H.</given-names></name><name><surname>Matsuguchi</surname><given-names>T.</given-names></name><name><surname>Yokokura</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Intestinal microflora: probiotics and autoimmunity.</article-title>
<source><italic>J. Nutr.</italic></source>
<volume>137</volume>
<fpage>798S</fpage>&#x02013;<lpage>802S</lpage>.<pub-id pub-id-type="pmid">17311978</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendon&#x000e7;a</surname><given-names>F. H.</given-names></name><name><surname>dos Santos</surname><given-names>S. S.</given-names></name><name><surname>de Faria</surname><given-names>I. S.</given-names></name><name><surname>Silva</surname><given-names>C. R.</given-names></name><name><surname>Jorge</surname><given-names>A. O.</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>M. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of probiotic bacteria on <italic>Candida</italic> presence and IgA anti-<italic>Candida</italic> in the oral cavity of elderly.</article-title>
<source><italic>Braz. Dent. J.</italic></source>
<volume>23</volume>
<fpage>534</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1590/S0103-64402012000500011</pub-id><pub-id pub-id-type="pmid">23306230</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Significance of dietary modulation of intestinal flora and intestinal environment.</article-title>
<source><italic>Biosci. Microflora</italic></source>
<volume>19</volume>
<fpage>15</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.12938/bifidus1996.19.15</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Development of functional foods.</article-title>
<source><italic>Biosci. Microb. Food Health</italic></source>
<volume>33</volume>
<fpage>117</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.12938/bmfh.33.117</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsuoka</surname><given-names>T.</given-names></name><name><surname>Kaneuchi</surname><given-names>C.</given-names></name></person-group> (<year>1977</year>). <article-title>Ecology of the bifidobacteria.</article-title>
<source><italic>Am. J. Clin. Nutr.</italic></source>
<volume>30</volume>
<fpage>1799</fpage>&#x02013;<lpage>1810</lpage>.<pub-id pub-id-type="pmid">920640</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyasawa-Hori</surname><given-names>H.</given-names></name><name><surname>Aizawa</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>Difference in the xylitol sensitivity of acid production among <italic>Streptococcus mutans</italic> strains and the biochemical mechanism.</article-title>
<source><italic>Oral Microbiol. Immunol.</italic></source>
<volume>21</volume>
<fpage>201</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-302X.2006.00273.x</pub-id><pub-id pub-id-type="pmid">16842502</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f6;ller</surname><given-names>N. P.</given-names></name><name><surname>Scholz-Ahrens</surname><given-names>K. E.</given-names></name><name><surname>Roos</surname><given-names>N.</given-names></name><name><surname>Schrezenmeir</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Bioactive peptides and proteins from foods: indication for health effects.</article-title>
<source><italic>Eur. J. Nutr.</italic></source>
<volume>47</volume>
<fpage>171</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-008-0710-2</pub-id><pub-id pub-id-type="pmid">18506385</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monagas</surname><given-names>M.</given-names></name><name><surname>Urpi-Sarda</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-Pat&#x000e1;n</surname><given-names>F.</given-names></name><name><surname>Llorach</surname><given-names>R.</given-names></name><name><surname>Garrido</surname><given-names>I.</given-names></name><name><surname>G&#x000f3;mez-Cordov&#x000e9;s</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.</article-title>
<source><italic>Food Funct.</italic></source>
<volume>1</volume>
<fpage>233</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1039/c0fo00132e</pub-id><pub-id pub-id-type="pmid">21776473</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Sakai</surname><given-names>K.</given-names></name><name><surname>Okubo</surname><given-names>A.</given-names></name><name><surname>Yamazaki</surname><given-names>S.</given-names></name><name><surname>Takano</surname><given-names>T.</given-names></name></person-group> (<year>1995</year>). <article-title>Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk.</article-title>
<source><italic>J. Dairy Sci.</italic></source>
<volume>78</volume>
<fpage>777</fpage>&#x02013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.3168/jds.S0022-0302(95)76745-5</pub-id><pub-id pub-id-type="pmid">7790570</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okkers</surname><given-names>D. J.</given-names></name><name><surname>Dicks</surname><given-names>L. M. T.</given-names></name><name><surname>Silvester</surname><given-names>M.</given-names></name><name><surname>Joubert</surname><given-names>J. J.</given-names></name><name><surname>Odendaal</surname><given-names>H. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from <italic>Lactobacillus pentosus</italic> with a fungistatic effect on <italic>Candida albicans</italic>.</article-title>
<source><italic>J. Appl. Microbiol.</italic></source>
<volume>87</volume>
<fpage>726</fpage>&#x02013;<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2672.1999.00918.x</pub-id><pub-id pub-id-type="pmid">10594714</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d4;nishi</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group> (<year>1966</year>). <article-title>The production of xylitol, L-arabinitol and ribitol by yeasts.</article-title>
<source><italic>Agric. Biol. Chem.</italic></source>
<volume>30</volume>
<fpage>1139</fpage>&#x02013;<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1271/bbb1961.30.1139</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Shea</surname><given-names>E. F.</given-names></name><name><surname>Cotter</surname><given-names>P. D.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.</article-title>
<source><italic>Int. J. Food Microbiol.</italic></source>
<volume>152</volume>
<fpage>189</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2011.05.025</pub-id><pub-id pub-id-type="pmid">21742394</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panigrahi</surname><given-names>P.</given-names></name><name><surname>Parida</surname><given-names>S.</given-names></name><name><surname>Pradhan</surname><given-names>L.</given-names></name><name><surname>Mohapatra</surname><given-names>S. S.</given-names></name><name><surname>Misra</surname><given-names>P. R.</given-names></name><name><surname>Johnson</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Long-term colonization of a lactobacillus symbiotic preparation in the neonatal gut.</article-title>
<source><italic>J. Pediatr. Gastroenterol. Nutr.</italic></source>
<volume>47</volume>
<fpage>45</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1097/MPG.0b013e31815a5f2c</pub-id><pub-id pub-id-type="pmid">18607268</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>L. M.</given-names></name><name><surname>Daniele</surname><given-names>M. B.</given-names></name><name><surname>Giordano</surname><given-names>W.</given-names></name><name><surname>Pajaro</surname><given-names>M. C.</given-names></name><name><surname>Barberis</surname><given-names>I. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Purification and partial characterization of novel bacteriocin L23 produced by <italic>Lactobacillus fermentum</italic> L23.</article-title>
<source><italic>Curr. Microbiol.</italic></source>
<volume>56</volume>
<fpage>397</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-007-9094-4</pub-id><pub-id pub-id-type="pmid">18172715</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaller</surname><given-names>M. A.</given-names></name><name><surname>Diekema</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Epidemiology of invasive candidiasis: a persistent public health problem.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>20</volume>
<fpage>133</fpage>&#x02013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00029-06</pub-id><pub-id pub-id-type="pmid">17223626</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piard</surname><given-names>J. C.</given-names></name><name><surname>Desmazeaud</surname><given-names>M.</given-names></name></person-group> (<year>1991</year>). <article-title>Inhibiting factors produced by lactic acid bacteria. 1. Oxygen metabolites and catabolism end-products.</article-title>
<source><italic>Lait</italic></source>
<volume>71</volume>
<fpage>525</fpage>&#x02013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1051/lait:1991541</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>G.</given-names></name><name><surname>Giuliana</surname><given-names>G.</given-names></name><name><surname>Milici</surname><given-names>M. E.</given-names></name><name><surname>Giangreco</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Effect of dietary carbohydrates on the in vitro epithelial adhesion of <italic>Candida albicans, Candida tropicalis</italic>, and <italic>Candida krusei</italic>.</article-title>
<source><italic>New Microbiol.</italic></source>
<volume>23</volume>
<fpage>63</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">10946407</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R. P.</given-names></name><name><surname>Mills</surname><given-names>S.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. F.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Specific metabolite production by gut microbiota as a basis for probiotic function.</article-title>
<source><italic>Int. Dairy J.</italic></source>
<volume>20</volume>
<fpage>269</fpage>&#x02013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.idairyj.2009.12.003</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salminen</surname><given-names>S.</given-names></name><name><surname>Bouley</surname><given-names>C.</given-names></name><name><surname>Boutron-Ruault</surname><given-names>M. C.</given-names></name><name><surname>Cummings</surname><given-names>J. H.</given-names></name><name><surname>Franck</surname><given-names>A.</given-names></name><name><surname>Gibson</surname><given-names>G. R.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Functional food science and gastrointestinal physiology and function.</article-title>
<source><italic>Br. J. Nutr.</italic></source>
<volume>80</volume>
<fpage>147</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1079/BJN19980108</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sardi</surname><given-names>J. C. O.</given-names></name><name><surname>Scorzoni</surname><given-names>L.</given-names></name><name><surname>Bernardi</surname><given-names>T.</given-names></name><name><surname>Fusco-Almeida</surname><given-names>A. M.</given-names></name><name><surname>Giannini</surname><given-names>M. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>62</volume>
<fpage>10</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.045054-0</pub-id><pub-id pub-id-type="pmid">23180477</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>D.</given-names></name><name><surname>Sugawara</surname><given-names>T.</given-names></name><name><surname>Ishida</surname><given-names>Y.</given-names></name><name><surname>Aihara</surname><given-names>K.</given-names></name><name><surname>Aoki</surname><given-names>Y.</given-names></name><name><surname>Takehara</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Effect of continuous ingestion of a beverage prepared with <italic>Lactobacillus gasseri</italic> CP2305 inactivated by heat treatment on the regulation of intestinal function.</article-title>
<source><italic>Food Res. Int.</italic></source>
<volume>79</volume>
<fpage>33</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2015.11.032</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scully</surname><given-names>C.</given-names></name><name><surname>Ei-Kabir</surname><given-names>M.</given-names></name><name><surname>Samaranayake</surname><given-names>L. P.</given-names></name></person-group> (<year>1994</year>). <article-title>Candida and oral candidosis: a review.</article-title>
<source><italic>Crit. Rev. Oral Biol. Med.</italic></source>
<volume>5</volume>
<fpage>125</fpage>&#x02013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">7858080</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action.</article-title>
<source><italic>Fungal Biol.</italic></source>
<volume>118</volume>
<fpage>264</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.funbio.2013.12.006</pub-id><pub-id pub-id-type="pmid">24528647</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shokryazdan</surname><given-names>P.</given-names></name><name><surname>Sieo</surname><given-names>C. C.</given-names></name><name><surname>Kalavathy</surname><given-names>R.</given-names></name><name><surname>Liang</surname><given-names>J. B.</given-names></name><name><surname>Alitheen</surname><given-names>N. B.</given-names></name><name><surname>Jahromi</surname><given-names>M. F.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Probiotic potential of <italic>Lactobacillus</italic> strains with antimicrobial activity against some human pathogenic strains.</article-title>
<source><italic>Biomed. Res. Int.</italic></source>
<volume>2014</volume>:<issue>927268</issue>
<pub-id pub-id-type="doi">10.1155/2014/927268</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutula</surname><given-names>J.</given-names></name><name><surname>Coulthwaite</surname><given-names>L. A.</given-names></name><name><surname>Thomas</surname><given-names>L. V.</given-names></name><name><surname>Verran</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>The effect of a commercial probiotic drink containing Lactobacillus <italic>casei</italic> strain Shirota on oral health in healthy dentate people.</article-title>
<source><italic>Microbiol. Ecol. Health Dis.</italic></source>
<volume>29</volume>:<issue>24</issue>
<pub-id pub-id-type="doi">10.3402/mehd.v24i0.21003</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takano</surname><given-names>T.</given-names></name><name><surname>Arai</surname><given-names>K.</given-names></name><name><surname>Murota</surname><given-names>I.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Mizutani</surname><given-names>T.</given-names></name><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>1985</year>). <article-title>Effects of feeding sour milk on longevity and tumorigenesis in mice and rats.</article-title>
<source><italic>Bifidobact. Microflora</italic></source>
<volume>4</volume>
<fpage>31</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.12938/bifidus1982.4.1_31</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talarico</surname><given-names>T. L.</given-names></name><name><surname>Casas</surname><given-names>I. A.</given-names></name><name><surname>Chung</surname><given-names>T. C.</given-names></name><name><surname>Dobrogosz</surname><given-names>W. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Production and isolation of reuterin, a growth inhibitor produced by <italic>Lactobacillus reuteri</italic>.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>32</volume>
<fpage>1854</fpage>&#x02013;<lpage>1858</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.32.12.1854</pub-id><pub-id pub-id-type="pmid">3245697</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>A.</given-names></name><name><surname>Bukawa</surname><given-names>W.</given-names></name><name><surname>Kan</surname><given-names>T.</given-names></name><name><surname>Mitsuoka</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Effects of the consumption of heat-killed Enterococcus faecalis EC-12 preparation on microbiota and metabolic activity of the faeces in healthy adults.</article-title>
<source><italic>Microbial. Ecol. Health Dis.</italic></source>
<volume>16</volume>
<fpage>188</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1080/08910600410017346</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiihonen</surname><given-names>K.</given-names></name><name><surname>Ouwehand</surname><given-names>A. C.</given-names></name><name><surname>Rautonen</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Human intestinal microbiota and healthy ageing.</article-title>
<source><italic>Ageing Res. Rev.</italic></source>
<volume>9</volume>
<fpage>107</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2009.10.004</pub-id><pub-id pub-id-type="pmid">19874918</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uittamo</surname><given-names>J.</given-names></name><name><surname>Nieminen</surname><given-names>M. T.</given-names></name><name><surname>Kaihovaara</surname><given-names>P.</given-names></name><name><surname>Bowyer</surname><given-names>P.</given-names></name><name><surname>Salaspuro</surname><given-names>M.</given-names></name><name><surname>Rautemaa</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Xylitol inhibits carcinogenic acetaldehyde production by Candida species.</article-title>
<source><italic>Int. J. Cancer</italic></source>
<volume>129</volume>
<fpage>2038</fpage>&#x02013;<lpage>2041</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.25844</pub-id><pub-id pub-id-type="pmid">21154745</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Houte</surname><given-names>J.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Pulkkinen</surname><given-names>A. J.</given-names></name></person-group> (<year>1972</year>). <article-title>Ecology of human oral lactobacilli.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>6</volume>
<fpage>723</fpage>&#x02013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">4637297</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>S. L.</given-names></name><name><surname>Patrick</surname><given-names>C. C.</given-names></name><name><surname>Ayers</surname><given-names>G. D.</given-names></name><name><surname>Hughes</surname><given-names>W. T.</given-names></name></person-group> (<year>1993</year>). <article-title>Modulating effect of dietary carbohydrate supplementation on <italic>Candida albicans</italic> colonization and invasion in a neutropenic mouse model.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>61</volume>
<fpage>619</fpage>&#x02013;<lpage>626</lpage>.<pub-id pub-id-type="pmid">8423091</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivekananda</surname><given-names>M. R.</given-names></name><name><surname>Vandana</surname><given-names>K. L.</given-names></name><name><surname>Bhat</surname><given-names>K. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Effect of the probiotic <italic>Lactobacilli reuteri</italic> (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial.</article-title>
<source><italic>J. Oral Microbiol.</italic></source>
<volume>2</volume>:<issue>2</issue>
<pub-id pub-id-type="doi">10.3402/jom.v2i0.5344</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>R. D.</given-names></name><name><surname>Pierson</surname><given-names>C.</given-names></name><name><surname>Warner</surname><given-names>T.</given-names></name><name><surname>Dohnalek</surname><given-names>M.</given-names></name><name><surname>Farmer</surname><given-names>J.</given-names></name><name><surname>Roberts</surname><given-names>L.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Biotherapeutic effects of probiotic bacteria on ca L ndidiasis in immunodeficient mice.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>65</volume>
<fpage>4165</fpage>&#x02013;<lpage>4172</lpage>.<pub-id pub-id-type="pmid">9317023</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Argimon</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Caufield</surname><given-names>P. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Determining the genetic diversity of lactobacilli from the oral cavity.</article-title>
<source><italic>J. Microbiol. Methods</italic></source>
<volume>82</volume>
<fpage>163</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.mimet.2010.05.010</pub-id><pub-id pub-id-type="pmid">20573585</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zal&#x000e1;n</surname><given-names>Z.</given-names></name><name><surname>Hud&#x000e1;&#x0010d;ek</surname><given-names>J.</given-names></name><name><surname>&#x00160;t&#x0011b;tina</surname><given-names>J.</given-names></name><name><surname>Chumchalov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Hal&#x000e1;sz</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Production of organic acids by <italic>Lactobacillus</italic> strains in three different media.</article-title>
<source><italic>Eur. Food Res. Technol.</italic></source>
<volume>230</volume>
<fpage>395</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1007/s00217-009-1179-9</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavisic</surname><given-names>G.</given-names></name><name><surname>Petricevic</surname><given-names>S.</given-names></name><name><surname>Radulovic</surname><given-names>Z.</given-names></name><name><surname>Begovic</surname><given-names>J.</given-names></name><name><surname>Golic</surname><given-names>N.</given-names></name><name><surname>Topisirovic</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Probiotic features of two oral Lactobacillus isolates.</article-title>
<source><italic>Braz. J. Microbiol.</italic></source>
<volume>43</volume>
<fpage>418</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1590/S1517-838220120001000050</pub-id><pub-id pub-id-type="pmid">24031847</pub-id></mixed-citation></ref></ref-list></back></article>